nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—mammary gland—breast cancer	0.114	0.17	CbGeAlD
Nitroxoline—METAP2—nipple—breast cancer	0.0941	0.141	CbGeAlD
Nitroxoline—METAP2—endometrium—breast cancer	0.0568	0.0851	CbGeAlD
Nitroxoline—METAP2—uterus—breast cancer	0.0524	0.0785	CbGeAlD
Nitroxoline—METAP2—pituitary gland—breast cancer	0.0514	0.077	CbGeAlD
Nitroxoline—METAP2—adipose tissue—breast cancer	0.0512	0.0767	CbGeAlD
Nitroxoline—METAP2—female reproductive system—breast cancer	0.0471	0.0705	CbGeAlD
Nitroxoline—METAP2—adrenal gland—breast cancer	0.046	0.0688	CbGeAlD
Nitroxoline—METAP2—bone marrow—breast cancer	0.0445	0.0666	CbGeAlD
Nitroxoline—METAP2—female gonad—breast cancer	0.0428	0.0642	CbGeAlD
Nitroxoline—METAP2—endocrine gland—breast cancer	0.0398	0.0597	CbGeAlD
Nitroxoline—METAP2—lymph node—breast cancer	0.0275	0.0413	CbGeAlD
Nitroxoline—METAP2—Disease—MFGE8—breast cancer	0.00497	0.0149	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CHST9—breast cancer	0.00434	0.0131	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LGR6—breast cancer	0.00411	0.0124	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CCDC88C—breast cancer	0.00411	0.0124	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SFRP1—breast cancer	0.00393	0.0118	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SHMT1—breast cancer	0.00376	0.0113	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A5—breast cancer	0.00362	0.0109	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HEYL—breast cancer	0.0035	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CUL5—breast cancer	0.0035	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RSPO3—breast cancer	0.00329	0.0099	CbGpPWpGaD
Nitroxoline—METAP2—Disease—WNT10B—breast cancer	0.0032	0.00963	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GPI—breast cancer	0.00312	0.00938	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DLL4—breast cancer	0.00297	0.00895	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCDC88C—breast cancer	0.00288	0.00867	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LGR6—breast cancer	0.00288	0.00867	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPL31—breast cancer	0.0028	0.00842	CbGpPWpGaD
Nitroxoline—METAP2—Disease—LDHB—breast cancer	0.0028	0.00842	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SFRP2—breast cancer	0.0028	0.00842	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HPSE—breast cancer	0.0028	0.00842	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SFRP1—breast cancer	0.00275	0.00827	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GPER1—breast cancer	0.00275	0.00827	CbGpPWpGaD
Nitroxoline—METAP2—Disease—VCP—breast cancer	0.00265	0.00798	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ABCC1—breast cancer	0.00265	0.00798	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HMMR—breast cancer	0.00265	0.00798	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NMBR—breast cancer	0.00264	0.00793	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFBI—breast cancer	0.00261	0.00785	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS4X—breast cancer	0.00261	0.00785	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ELL—breast cancer	0.00249	0.0075	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CUL5—breast cancer	0.00245	0.00737	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTGER1—breast cancer	0.00245	0.00737	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HEYL—breast cancer	0.00245	0.00737	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HEY2—breast cancer	0.00233	0.00702	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS6KB2—breast cancer	0.00231	0.00694	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RSPO3—breast cancer	0.0023	0.00693	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IDH1—breast cancer	0.00228	0.00686	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—WNT10B—breast cancer	0.00224	0.00674	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—WWOX—breast cancer	0.00224	0.00674	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL3—breast cancer	0.00218	0.00657	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDE2A—breast cancer	0.00218	0.00657	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL27—breast cancer	0.00218	0.00657	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—INHBB—breast cancer	0.00218	0.00657	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TLE3—breast cancer	0.00218	0.00657	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HEY1—breast cancer	0.00216	0.0065	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DLL1—breast cancer	0.00212	0.00638	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPL23A—breast cancer	0.00212	0.00638	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DLL4—breast cancer	0.00208	0.00627	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BMPR2—breast cancer	0.00208	0.00627	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAP2K7—breast cancer	0.00208	0.00626	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HIST1H2BK—breast cancer	0.00208	0.00626	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HIST1H2BC—breast cancer	0.00208	0.00626	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDH5—breast cancer	0.002	0.00601	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS8—breast cancer	0.00198	0.00595	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS7—breast cancer	0.00198	0.00595	CbGpPWpGaD
Nitroxoline—METAP2—Disease—DKK1—breast cancer	0.00196	0.0059	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SFRP2—breast cancer	0.00196	0.00589	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ALDOA—breast cancer	0.00195	0.00586	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRLR—breast cancer	0.00192	0.00578	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JAG2—breast cancer	0.00192	0.00577	CbGpPWpGaD
Nitroxoline—METAP2—Disease—WNT1—breast cancer	0.00189	0.00568	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A2—breast cancer	0.00188	0.00564	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VCP—breast cancer	0.00186	0.00559	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GLI2—breast cancer	0.00186	0.00559	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTR—breast cancer	0.00184	0.00553	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEPR—breast cancer	0.00183	0.0055	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HSPA1B—breast cancer	0.00171	0.00514	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ARHGDIA—breast cancer	0.0017	0.00511	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FST—breast cancer	0.00165	0.00498	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ENO1—breast cancer	0.00164	0.00493	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HEY2—breast cancer	0.00163	0.00492	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RPS6KB2—breast cancer	0.00162	0.00486	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RGS2—breast cancer	0.0016	0.0048	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCL20—breast cancer	0.00158	0.00475	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF3—breast cancer	0.00155	0.00466	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FASN—breast cancer	0.00153	0.0046	CbGpPWpGaD
Nitroxoline—METAP2—Disease—JAG1—breast cancer	0.00153	0.0046	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TLE3—breast cancer	0.00153	0.0046	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LPAR1—breast cancer	0.00153	0.0046	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PARP1—breast cancer	0.00152	0.00458	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HEY1—breast cancer	0.00151	0.00455	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CALCA—breast cancer	0.0015	0.00453	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPS6—breast cancer	0.00149	0.00447	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DLL1—breast cancer	0.00148	0.00447	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF4—breast cancer	0.00147	0.00444	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CXCR4—breast cancer	0.00147	0.00442	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HIST1H2BK—breast cancer	0.00146	0.00438	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HIST1H2BC—breast cancer	0.00146	0.00438	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A1—breast cancer	0.00145	0.00437	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GRB7—breast cancer	0.00144	0.00434	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDE4D—breast cancer	0.00144	0.00434	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TAB2—breast cancer	0.00142	0.00427	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TCF7L2—breast cancer	0.00142	0.00426	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CNR2—breast cancer	0.00141	0.00423	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—DKK1—breast cancer	0.00137	0.00413	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HSP90AA1—breast cancer	0.00137	0.00411	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFC—breast cancer	0.00136	0.0041	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAG2—breast cancer	0.00134	0.00404	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRL—breast cancer	0.00133	0.004	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—WNT1—breast cancer	0.00132	0.00398	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ADAM10—breast cancer	0.00131	0.00394	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF10—breast cancer	0.00127	0.00383	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH4—breast cancer	0.00125	0.00377	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GZMB—breast cancer	0.00125	0.00375	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PDGFA—breast cancer	0.00123	0.0037	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFBR2—breast cancer	0.00121	0.00365	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL2—breast cancer	0.00121	0.00364	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGTR2—breast cancer	0.00121	0.00364	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTHLH—breast cancer	0.0012	0.0036	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BMP2—breast cancer	0.0012	0.0036	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ITPR1—breast cancer	0.00119	0.00359	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT5A—breast cancer	0.00118	0.00356	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERBB4—breast cancer	0.00118	0.00356	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EDNRB—breast cancer	0.00116	0.00349	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PGR—breast cancer	0.00115	0.00345	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SMAD4—breast cancer	0.00115	0.00345	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—THBS1—breast cancer	0.00114	0.00343	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HES1—breast cancer	0.00112	0.00337	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NCOR1—breast cancer	0.00111	0.00335	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF1—breast cancer	0.0011	0.00331	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NRG1—breast cancer	0.00109	0.00329	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FLT1—breast cancer	0.00109	0.00328	CbGpPWpGaD
Nitroxoline—METAP2—Disease—H2AFX—breast cancer	0.00109	0.00326	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SQSTM1—breast cancer	0.00108	0.00326	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF3—breast cancer	0.00108	0.00326	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JAG1—breast cancer	0.00107	0.00322	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PARP1—breast cancer	0.00107	0.00321	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH3—breast cancer	0.00107	0.00321	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CALCA—breast cancer	0.00105	0.00317	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERCC2—breast cancer	0.00105	0.00315	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RPS6—breast cancer	0.00104	0.00313	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF4—breast cancer	0.00103	0.00311	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL12—breast cancer	0.00103	0.0031	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCR4—breast cancer	0.00103	0.0031	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERBB3—breast cancer	0.00102	0.00308	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGFR2—breast cancer	0.00102	0.00308	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PAK1—breast cancer	0.00101	0.00304	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TCF7L2—breast cancer	0.000992	0.00298	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTHFR—breast cancer	0.000984	0.00296	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TERT—breast cancer	0.000981	0.00295	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH2—breast cancer	0.000957	0.00288	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HSP90AA1—breast cancer	0.000957	0.00288	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGFR1—breast cancer	0.000953	0.00287	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HIF1A—breast cancer	0.000939	0.00282	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AGTR1—breast cancer	0.00093	0.0028	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRL—breast cancer	0.00093	0.0028	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADAM10—breast cancer	0.000917	0.00276	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STK11—breast cancer	0.000917	0.00276	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CAV1—breast cancer	0.000908	0.00273	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLG—breast cancer	0.000907	0.00273	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF10—breast cancer	0.000892	0.00268	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDGFA—breast cancer	0.000861	0.00259	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS2—breast cancer	0.000854	0.00257	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TGFBR2—breast cancer	0.000849	0.00255	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOTCH1—breast cancer	0.000845	0.00254	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ITPR1—breast cancer	0.000835	0.00251	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP3—breast cancer	0.000829	0.0025	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ERBB4—breast cancer	0.000829	0.0025	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT5A—breast cancer	0.000829	0.0025	CbGpPWpGaD
Nitroxoline—METAP2—Disease—APC—breast cancer	0.000827	0.00249	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KIT—breast cancer	0.000827	0.00249	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGF—breast cancer	0.000817	0.00246	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SMAD4—breast cancer	0.000803	0.00242	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1R—breast cancer	0.000798	0.0024	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HES1—breast cancer	0.000784	0.00236	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NCOR1—breast cancer	0.00078	0.00235	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLA2G4A—breast cancer	0.00078	0.00235	CbGpPWpGaD
Nitroxoline—METAP2—Disease—BRAF—breast cancer	0.000777	0.00234	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CSF2—breast cancer	0.000771	0.00232	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF1—breast cancer	0.000771	0.00232	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NRG1—breast cancer	0.000765	0.0023	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—H2AFX—breast cancer	0.00076	0.00229	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT2—breast cancer	0.000756	0.00228	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—E2F1—breast cancer	0.000755	0.00227	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CD—breast cancer	0.000727	0.00219	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SPP1—breast cancer	0.000725	0.00218	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SERPINE1—breast cancer	0.000719	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ERBB3—breast cancer	0.000717	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGFR2—breast cancer	0.000716	0.00215	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TERT—breast cancer	0.000687	0.00207	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NOS3—breast cancer	0.000686	0.00207	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGFR1—breast cancer	0.000667	0.00201	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HIF1A—breast cancer	0.000657	0.00198	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MDM2—breast cancer	0.000651	0.00196	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RAF1—breast cancer	0.000649	0.00195	CbGpPWpGaD
Nitroxoline—METAP2—Disease—ERBB2—breast cancer	0.000642	0.00193	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEP—breast cancer	0.000642	0.00193	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CAV1—breast cancer	0.000636	0.00191	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CB—breast cancer	0.000634	0.00191	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTOR—breast cancer	0.000634	0.00191	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CD4—breast cancer	0.000632	0.0019	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KDR—breast cancer	0.000629	0.00189	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTGS2—breast cancer	0.000628	0.00189	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ESR1—breast cancer	0.000613	0.00184	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FN1—breast cancer	0.000605	0.00182	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NFKBIA—breast cancer	0.000598	0.0018	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1B—breast cancer	0.000595	0.00179	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOTCH1—breast cancer	0.000592	0.00178	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KIT—breast cancer	0.000579	0.00174	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—APC—breast cancer	0.000579	0.00174	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CG—breast cancer	0.000579	0.00174	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGF—breast cancer	0.000572	0.00172	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CTNNB1—breast cancer	0.000562	0.00169	CbGpPWpGaD
Nitroxoline—METAP2—Disease—CDKN1A—breast cancer	0.000549	0.00165	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PTEN—breast cancer	0.000547	0.00165	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—BRAF—breast cancer	0.000544	0.00164	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1—breast cancer	0.00053	0.0016	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT2—breast cancer	0.00053	0.00159	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CD—breast cancer	0.000509	0.00153	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SRC—breast cancer	0.000508	0.00153	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SERPINE1—breast cancer	0.000503	0.00151	CbGpPWpGaD
Nitroxoline—METAP2—Disease—STAT3—breast cancer	0.00049	0.00147	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NOS3—breast cancer	0.000481	0.00145	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MAPK3—breast cancer	0.000468	0.00141	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MDM2—breast cancer	0.000456	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MYC—breast cancer	0.000455	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RAF1—breast cancer	0.000454	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TGFB1—breast cancer	0.000454	0.00137	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RELA—breast cancer	0.000452	0.00136	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ERBB2—breast cancer	0.00045	0.00135	CbGpPWpGaD
Nitroxoline—METAP2—Disease—EGFR—breast cancer	0.000445	0.00134	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MTOR—breast cancer	0.000444	0.00133	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CB—breast cancer	0.000444	0.00133	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CXCL8—breast cancer	0.000426	0.00128	CbGpPWpGaD
Nitroxoline—METAP2—Disease—KRAS—breast cancer	0.00042	0.00126	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1B—breast cancer	0.000416	0.00125	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CASP3—breast cancer	0.000408	0.00123	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL2—breast cancer	0.000407	0.00123	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CCND1—breast cancer	0.000397	0.0012	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—JUN—breast cancer	0.000396	0.00119	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CTNNB1—breast cancer	0.000393	0.00118	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PIK3CA—breast cancer	0.000386	0.00116	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MMP9—breast cancer	0.000386	0.00116	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—CDKN1A—breast cancer	0.000384	0.00116	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTEN—breast cancer	0.000383	0.00115	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK8—breast cancer	0.000375	0.00113	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HRAS—breast cancer	0.000357	0.00108	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SRC—breast cancer	0.000356	0.00107	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—breast cancer	0.000346	0.00104	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—STAT3—breast cancer	0.000343	0.00103	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—breast cancer	0.000342	0.00103	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MAPK3—breast cancer	0.000328	0.000986	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MYC—breast cancer	0.000319	0.000959	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TGFB1—breast cancer	0.000318	0.000956	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT1—breast cancer	0.000316	0.000949	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—EGFR—breast cancer	0.000312	0.000938	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—KRAS—breast cancer	0.000294	0.000886	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PIK3CA—breast cancer	0.00027	0.000814	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TP53—breast cancer	0.000262	0.000787	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—HRAS—breast cancer	0.00025	0.000753	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—breast cancer	0.000239	0.000721	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT1—breast cancer	0.000221	0.000665	CbGpPWpGaD
